LIM
Lagoda Investment Management Portfolio holdings
AUM
$177M
This Quarter Return
+17.82%
1 Year Return
+46.81%
3 Year Return
+194.86%
5 Year Return
+427.13%
10 Year Return
+1,154.94%
AUM
$333M
AUM Growth
+$333M
(+24%)
Cap. Flow
+$28.3M
Cap. Flow
% of AUM
8.51%
Top 10 Holdings %
Top 10 Hldgs %
70.78%
Holding
29
New
1
Increased
14
Reduced
8
Closed
–
Top Buys
| 1 |
MON
Monsanto Co
MON
|
$10.1M |
| 2 |
VolitionRX
VNRX
|
$6.92M |
| 3 |
Ubiquiti
UI
|
$6.65M |
| 4 |
TTOO
T2 Biosystems, Inc
TTOO
|
$3.34M |
| 5 |
Digimarc
DMRC
|
$1.9M |
Top Sells
| 1 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
$2.37M |
| 2 |
Novo Nordisk
NVO
|
$1.27M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
$432K |
| 4 |
ESGR
Enstar Group
ESGR
|
$392K |
| 5 |
Mastercard
MA
|
$350K |
Sector Composition
| 1 | Healthcare | 48.15% |
| 2 | Technology | 20.9% |
| 3 | Communication Services | 12.14% |
| 4 | Financials | 9.29% |
| 5 | Materials | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
| $30.6M | 9.21% |
567,057
+1,814
| +0.3% | +$98K |
|
2
Regeneron Pharmaceuticals
REGN
$61.5B
| $29.4M | 8.84% |
73,131
+393
| +0.5% | +$158K |
|
3
RenaissanceRe
RNR
$11.4B
| $25.1M | 7.54% |
208,602
+28
| +0% | +$3.37K |
|
|
4
Digimarc
DMRC
$188M
| $25M | 7.52% |
651,878
+49,428
| +8% | +$1.9M |
|
5
PTC
PTC
$25.6B
| $22.5M | 6.78% |
508,763
+13,370
| +3% | +$592K |
|
|
6
Ubiquiti
UI
$32B
| $22M | 6.6% |
410,421
+124,284
| +43% | +$6.65M |
|
7
Alphabet (Google) Class C
GOOG
$2.58T
| $21.7M | 6.52% |
27,870
+476
| +2% | +$370K |
|
|
SNMX
8
DELISTED
Senomyx, Inc.
SNMX
| $20.7M | 6.21% |
4,849,662
+397,234
| +9% | +$1.69M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $19.3M | 5.82% |
157,853
+293
| +0.2% | +$35.9K |
|
|
10
Novo Nordisk
NVO
$251B
| $19.1M | 5.75% |
459,542
-30,506
| -6% | -$1.27M |
|
|
MON
11
DELISTED
Monsanto Co
MON
| $17.9M | 5.38% |
175,123
+98,925
| +130% | +$10.1M |
|
|
12
VolitionRX
VNRX
$74.2M
| $15.5M | 4.67% |
2,927,492
+1,306,218
| +81% | +$6.92M |
|
|
TTOO
13
DELISTED
T2 Biosystems, Inc
TTOO
| $13.6M | 4.1% |
1,881,934
+461,306
| +32% | +$3.34M |
|
14
Precigen
PGEN
$1.34B
| $13.5M | 4.05% |
480,207
+10,283
| +2% | +$288K |
|
|
MACK
15
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $11.9M | 3.57% |
1,870,777
-373,303
| -17% | -$2.37M |
|
16
Baidu
BIDU
$32.8B
| $9.76M | 2.93% |
53,579
+4,574
| +9% | +$833K |
|
|
17
Alphabet (Google) Class A
GOOGL
$2.57T
| $8.96M | 2.69% |
11,141
-90
| -0.8% | -$72.4K |
|
|
ESGR
18
DELISTED
Enstar Group
ESGR
| $3.21M | 0.97% |
19,528
-2,382
| -11% | -$392K |
|
|
19
Mastercard
MA
$538B
| $1.83M | 0.55% |
17,935
-3,443
| -16% | -$350K |
|
|
20
Berkshire Hathaway Class A
BRK.A
$1.09T
| $432K | 0.13% |
2
-2
| -50% | -$432K |
|
|
21
Berkshire Hathaway Class B
BRK.B
$1.09T
| $202K | 0.06% |
+1,400
| New | +$202K |
|
|
Y
22
DELISTED
Alleghany Corporation
Y
| $142K | 0.04% |
270
| – | – |
|
23
Exxon Mobil
XOM
$487B
| $62K | 0.02% |
715
| – | – |
|
24
ConocoPhillips
COP
$124B
| $54K | 0.02% |
1,231
-119
| -9% | -$5.22K |
|
25
Pfizer
PFE
$141B
| $50K | 0.02% |
1,477
-60
| -4% | -$2.03K |
|